Constitutive and cytokine-regulated expression of presenilin-1 and presenilin-2 genes in human neural cell lines

Neuropathology and Applied Neurobiology

Volumn 25, Issue 6, 1999, Pages 492-503

  Satoh, J I ^a   Kuroda, Y ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Cytokines; Human neural cell lines; Northern blotting; Presenilin 1; Presenilin 2

Indexed keywords

BUCLADESINE; CYTOKINE; INTERLEUKIN 10; MESSENGER RNA; PHORBOL DIACETATE; PRESENILIN 1; PRESENILIN 2; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; ASTROCYTOMA CELL; CELL TYPE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NERVE CELL; NEUROBLASTOMA; NORTHERN BLOTTING; PLEIOTROPY; PRIORITY JOURNAL;

BUCLADESINE; CELL DIFFERENTIATION; CYTOKINES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-10; MEMBRANE PROTEINS; NEOPLASMS, NERVE TISSUE; NEURONS; PRESENILIN-1; PRESENILIN-2; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TISSUE DISTRIBUTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033368981     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.1999.00209.x     Document Type: Article

References (60)

1. 1 Aisen PS, Davis KL. Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am J Psychiatry 1994; 151: 1105-13
2. 2 Angel P, Karin M. The role of Jun, Fos, and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991; 1072: 129-57
3. 3 Araujo DM, Cotman CW. β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res 1992; 569: 141-5
4. 4 Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 1992; 263: C1-C16
5. 5 Buxbaum JD, Oishi M, Chen HI et al. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc Natl Acad Sci USA 1992; 89: 10075-8
6. 6 Capell A, Saffrich R, Olivo J-C et al. Cellular expression and proteolytic processing of presenilin proteins is developmentally regulated during neuronal differentiation. J Neurochem 1997; 69: 2432-40
7. 7 Citron M, Westaway D, Xia W et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med 1997; 3: 67-72
8. 8 Coggins PJ, Zwiers H. B-50 (GAP-43): biochemistry and functional neurochemistry of a neuron-specific phosphoprotein. J Neurochem 1991; 56: 1095-106
9. 9 Cribbs DH, Chen L-S, Cotman CW, LaFerla FM. Injury induces presenilin-1 gene expression in mouse brain. Neuroreport 1996; 7: 1773-6
10. 10 Derynck R. Transforming growth factor-beta. In The Cytokine Handbook, Ed. A Thomson. San Diego: Academic Press, 1994: 319-42
11. 11 De Strooper B, Saftig P, Craessaerts K et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 1998; 391: 387-90
12. 12 Dickson DW, Lee SC, Mattiace LA, Yen S-HC, Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993; 7: 75-83
13. 13 Forloni G, Demicheli F, Giorgi S, Bendotti C, Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Mol Brain Res 1992; 16: 128-34
14. 14 Giannakopoulos P, Bouras C, Kövari E et al. Presenilin-1-immunoreactive neurons are preserved in late-onset Alzheimer's disease. Am J Pathol 1997; 150: 429-36
15. 15 Goodwin RG, Cerretti DP, Smith CA. Cytokine receptors. In: Cytokines and the CNS, Eds RM Ransohoff, EN Benveniste. Boca Raton: CRC Press, 1996: 5-23
16. 16 Grant AL, Wisden W. Neuron-specific gene expression. In: Molecular Biology of the Neuron, Eds RW Davies, BJ Morris. Oxford: Oxford University Press, 1997: 67-93
17. 17 Griffin WST, Sheng JG, Royston MC et al. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol 1998; 8: 65-72
18. 18 Guo Q, Sopher BL, Furukawa K et al. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid β-peptide: involvement of calcium and oxyradicals. J Neurosci 1997; 17: 4212-22
19. 19 Haass C. Presenile because of presenilin: the presenilin genes and early onset Alzheimer's disease. Curr Opin Neurol 1996; 9: 254-9
20. 20 Hahn M, Lorez H, Fischer G. Effects of calcitriol on combination with corticosterone, inlerleukin-1β, and transforming growth factor-β1 on nerve growth factor secretion in an astroglial cell line. J Neurochem 1997; 69: 102-9
21. 21 Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 1997; 20: 154-9
22. 22 Hartmann H, Busciglio J, Baumann K-H, Staufenbiel M, Yanker BA. Developmental regulation of presenilin-1 processing in the brain suggests a role in neuronal differentiation. J Biol Chem 1997; 272: 14505-8
23. 23 Hung AY, Koo EH, Haass C, Selkoe DJ. Increased expression of β-amyloid precursor protein during neuronal differentiation is not accompanied by secretory cleavage. Proc Natl Acad Sci USA 1992; 89: 9439-43
24. 24 König G, Masters CL, Beyreuther K. Retinoic acid induced differentiated neuroblastoma cells show increased expression of the βA4 amyloid gene of Alzheimer's disease and an altered splicing pattern. FEBS Lett 1990; 269: 305-10
25. 25 Kovacs DM, Fausett HJ, Page KJ et al. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature Med 1996; 2: 224-9
26. 26 Kuppner MC, McKillop-Smith S, Forrester JV. TGF-β and IL-1β act in synergy to enhance IL-6 and IL-8 mRNA levels and IL-6 production by human retinal pigment epithelial cells. Immunology 1995; 84: 265-71
27. 27 Lahiri DK, Nall C. Promoter activity of the gene encoding the beta-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1. Mol Brain Res 1995; 32: 233-40
28. 28 Leaman DW, Leung S, Li X, Stark GR. Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J 1996; 10: 1578-88
29. 29 Lee MK, Slunt HH, Martin LJ et al. Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J Neurosci 1996; 16: 7513-25
30. 30 Levitan D, Greenwald I. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 1995; 377: 351-4
31. 31 Levy-Lahad E, Wasco W, Poorkaj P et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269: 973-7
32. 32 Mattson MP, Barger SW, Furukawa K et al. Cellular signaling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease. Brain Res Rev 1997; 23: 47-61
33. 33 Mattson MP, Guo Q, Furukawa K, Pedersen WA. Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. J Neurochem 1998; 70: 1-14
34. 34 McGeer PL, McGeer EG. The inflammatory response system of the brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 1995; 21: 195-218
35. 35 McMillan PJ, Leverenz JB, Poorkaj P, Schellenberg GD, Dorsa DM. Neuronal expression of STM2 mRNA in human brain is reduced in Alzheimer's disease. J Histochem Cytochem 1996; 44: 1215-22
36. 36 Meda L, Cassatella MA, Szendrei GI et al. Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 1995; 374: 647-50
37. 37 Mehler MF, Kessler JA. Hematolymphopoietic and inflammatory cytokines in neural development. Trends Neurosci 1997; 20: 357-65
38. 38 Mrak RE, Sheng JG, Griffin ST. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum Pathol 1995; 26: 816-23
39. 39 Pennypacker KR, Fuldner R, Xu R et al. Cloning and characterization of the presenilin-2 gene promoter. Mol Brain Res 1998; 56: 57-65
40. 40 Pleasure SJ, Page C, Lee VM-Y. Pure, postmitotic, polarized human neurons derived from NTera2 cells provide a system for expressing exogeneous proteins in terminally differentiated neurons. J Neurosci 1992; 12: 1802-15
41. 41 Rogaev EI, Sherrington R, Rogaeva EA et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995; 376: 775-8
42. 42 Rogaev EI, Sherrington R, Wu C et al. Analysis of the 5′ sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease. Genomics 1997; 40: 415-24
43. 43 Sahara N, Yahagi Y-I, Takagi H et al. Identification and characterization of presenilin I-467, I-463 and I-374. FEBS Lett 1996; 381: 7-11
44. 44 Satoh J-I, Yukitake M, Kurohara K, Kuroda Y. Retinoic acid-induced neuronal differentiation regulates expression of mRNAs for neurotrophins and neurotrophin receptors in a human embryonal carcinoma cell line NTera2. Neuropathology 1997; 17: 80-8
45. 45 Satoh J-I, Kurohara K, Yukitake M, Kuroda Y. Constitutive and cytokine-inducible expression of prion protein gene in human neural cell lines. J Neuropathol Exp Neurol 1998; 57: 131-9
46. 46 Satoh J-I, Kurohara K, Yukitake M, Kuroda Y. Interleukin-15, a T-cell growth factor, is expressed in human neural cell lines and tissues. J Neurol Sci 1998; 155: 170-7
47. 47 Satoh J-I, Yukitake M, Kuroda Y. Constitutive and heat-inducible expression of HSP105 in neurons and glial cells in culture. Neuroreport 1998; 9: 2977-83
48. 48 Sawada M, Suzumura A, Marunouchi T. Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells. Int J Dev Neurosci 1995; 13: 253-64
49. 49 Scheuner D, Eckman C, Jensen M et al. Secreted amyloid β-protein similar to that in senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med 1996; 2: 864-70
50. 50 Seeger M, Nordstedt C, Petanceska S et al. Evidence for phosphorylalion and oligomeric assembly of presenilin 1. Proc Natl Acad Sci USA 1997; 94: 5090-4
51. 51 Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S. Skeletal and CNS defects in presenilin-1-deficient mice. Cell 1997; 89: 629-39
52. 52 Sherrington R, Rogaev EI, Liang Y et al. Cloning of a gene bearing missense mutations in early-onset Alzheimer's disease. Nature 1995; 375: 754-60
53. 53 Takami K, Terai K, Matsuo A, Walker DC, McGeer PL. Expression of presenilin-1 and -2 mRNAs in rat and Alzheimer's disease brains. Brain Res 1997; 748: 122-30
54. 54 Van Broeckhoven C. Presenilins and Alzheimer disease. Nature Genet 1995; 11: 230-2
55. 55 van der Wal EA, Gómez-Pinilla F, Cotman CW. Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies. Neuroreport 1993; 4: 69-72
56. 2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 1996; 271: 521-5
57. 57 Wyss-Coray T, Masliah E, Mallory M et al. Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease. Nature 1997; 389: 603-6
58. 58 Wolfe MS, Xia W, Ostaazewski BL, Diehl TS, Kimberly WT, Selkoe DJ. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature 1999; 398: 513-7
59. 59 Wong PC, Zheng H, Chen H et al. Presenilin 1 is required for Notch1 and DLL1 expression in the paraxial mesoderm. Nature 1997; 387: 288-92
60. 60 Zeller M, Strauss WL. Retinoic acid induces cholinergic differentiation of NTera2 human embryonal carcinoma cells. Int J Dev Neurosci 1995; 13: 437-45